Local Anesthesia Drugs Market

Global Local Anesthesia Drugs Market Size, Trends & Analysis - Forecasts to 2026 By Product (Bupivacaine, Ropivacaine, Lidocaine, Chloroprocaine, Prilocaine, Benzocaine), By Application (Injectable, Surface Anesthetic), By Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Other), By Region (North America, Europe, Asia Pacific, MEA, and CSA); End-User Landscape, Vendor Landscape, and Company Market Share Analysis and Competitor Analysis

Category Healthcare

Format

This report was recently updated on April 16 2024 with the latest and most recent market numbers

Local Anesthesia Drugs Market Insights

The global local anesthesia drugs market is estimated to be valued at USD 5.60 billion in 2021 and is projected to reach USD 6.75 billion by 2026 at a CAGR of 3.8%. The core drivers which contribute to the market expansion include the increasing volume of surgeries related to chronic diseases, cardiovascular, accidents, cancer, nervous disorders and even getting relief from post-surgery. Moreover, the growing patient pool, rising geriatric population, increasing technological advancements, soaring requirement and inclination for innovative drugs, upsurge in government initiatives, rising cosmetic surgeries are acting as a growth catalyst. Additionally, rising funding on healthcare, burgeoning investments from key players, increasing new pipeline product launches, and increasing research & development activities will boost the market development.

In the anaesthetics business, growing concentration in the form of mergers is becoming more common. This is mostly because of the significant degree of research & development and intellectual property investments required to start anesthetic medication manufacturing companies. Mergers and acquisitions are seen as time-efficient and cost-effective approaches in this aspect. Specialized operating and other medical procedures can be administered to patients without causing them excessive pain or anguish, according to the law. Anesthetic procedures are used in a variety of ways when doing eye surgery. The need for local anesthetics in surgical procedures is predicted to increase as drug delivery methods improve. The introduction of novel and effective medications like articaine, levobupivacaine, and ropivacaine has further spurred market expansion for local anesthetic medications.

The use of local anesthesia in the treatment of COVID-19 affected individuals is in increased demand owing to its rewards and low risk of viral transmission. Furthermore, according to a study published in the European Archives of Oto-Rhino-Laryngology in 2020, topical oropharyngeal lignocaine implementation considerably expanded patient contentment thresholds throughout oropharyngeal sampling for COVID-19 but had no influence on the identification of SARS-CoV-2 in the upper airway. As a result, the researchers concluded that topical oropharyngeal lignocaine must be recognized as a method to minimize infectious inoculum sampling in a COVID-19 suspect.

global local anesthesia drugs market

Local Anesthesia Drugs Market: By Product

Based on product, the market is segmented into Bupivacaine, Ropivacaine, Lidocaine, Chloroprocaine, Prilocaine, Benzocaine.

During the forecast period, the market for Lidocaine is estimated to predominate. Rising dental surgeries, growing geriatric population, increasing periodontal diseases, growing need for surgeries, increasing investments in R&D, growing demand for anesthetic medications, increasing patient pool are driving this segment forward.

During the forecast period, the market for the Bupivacaine segment is estimated to grow the fastest. Bupivacaine just relieves pain, it cannot cause sleep or unconsciousness, so the market is growing due to the need to relieve pain after surgeries and labor pain management.

The other segments like Ropivacaine, Chloroprocaine, Prilocaine, Benzocaine are estimated to grow in the coming year due to growing investments and increasing chronic disease surgeries which need the pain to relieve injections.

Local Anesthesia Drugs Market: By Application

Based on the mode of application, the market is segmented into injectable and surface anesthetics.

During the forecast period, the injectable segment is estimated to predominate. The rapid increase in chronic diseases, ease of administration, advancing technologies, `increasing patients demanding surgeries, rising adoption of injectables are driving the segment forward.

During the forecast period, the surface anesthetic is estimated to grow the fastest. Surface Anesthetic is used for small surgeries. Increasing accidents, dental diseases, are driving this segment.

Local Anesthesia Drugs Market: By Distribution Channel

Based on the distribution channel, the market is segmented into hospital pharmacies, pharmacy stores, and others.

During the forecast period, the market for the hospital pharmacy segment is estimated to predominate because of the readily available modern equipment and technology in hospital settings. Hospitals will benefit even more from the presence of qualified and skilled healthcare staff. The market will grow as the number of individuals suffering from chronic diseases rises, demand for post-surgery relief, increasing accidents, healthcare spending rises, health consciousness and awareness rises, and obesity, diabetes, and cardiovascular illnesses become more prevalent. Healthcare and diagnostic facilities are in increasing demand in industrialized countries. Studies on therapies for terminal illness have benefited from advanced medical technology, as has early disease detection. Hospitals also have easy access to a wide range of medication as well as sufficient supplies on hand, which leads to their supremacy.

asia pacific local anesthesia drugs market

Local Anesthesia Drugs Market: By Region

As per the geographical analysis, the market can be classified into North America (the US, Canada, and Mexico), Asia Pacific (India, China, Japan, Malaysia, Singapore, and Rest of Asia Pacific), Europe (Germany, United Kingdom, Italy, France, Spain, Netherlands, and Rest of Europe), Middle East & Africa and Central & South America.

During the forecast period, the market for North America is estimated to predominate due to rising healthcare investments with well-established infrastructure and technological advancements. The supremacy is also due to a rise in the number of patients with obesity, diabetics, and heart diseases. Additionally, private and public agencies collaborate and partner strategically to improve outcomes in the treatment in the area.

Also, Europe is likely to be the second-largest market due to the increasing generic population, demand for post-surgery relief, and increasing chronic diseases. The European region has supportive reimbursement facilities for instruments and devices which will aid in increasing key players by introducing new products and thus the market is more likely to generate revenue.

The Asia Pacific is likely to rise at the fastest rate during the forecast period. This is due to the rising genetic disease incidence, increasing accidents & dental disorders, increasing demand for post-surgery pain relief, owing to an increasing patient pool and consumers' ability to pay for healthcare services. Rapidly expanding research and development activities are aiding in this region’s growth.

Local Anesthesia Drugs Market Share and Competitor Analysis

Fresenius Kabi USA, LLC, Pfizer Inc., Advanced Pharma, Inc., Akorn, Inc. Teva Pharmaceutical Industries Ltd., Akorn, Inc., Glenmark Pharmaceuticals, Inc., Baxter International, Inc., AstraZeneca PLC, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Hikma Pharmaceuticals PLC, Hospira, Inc., AbbVie Inc., Fresenius Se & Co. Kgaa, and Novartis AG, are the key players in the market.

Please note: This is not an exhaustive list of companies profiled in the report.

Chapter 1 Methodology

1.1 Market Scope & Definitions

1.2 Estimates & Forecast Calculation

1.3 Historical Data Overview And Validation

1.4 Data Sources

1.4.1 Secondary

1.4.2 Primary

Chapter 2 Report Outlook

2.1 Local Anesthesia Drugs Industry Overview, 2019-2026

2.1.1 Industry Overview

2.1.2 Product Overview

2.1.3 Application Overview

2.1.4 Distribution Channel Overview

2.1.5 Regional Overview

Chapter 3 Local Anesthesia Drugs Market Trends

3.1 Market Segmentation

3.2 Industry Background, 2019-2026

3.3 Market Key Trends

3.3.1 Positive Trends

3.3.1.1 Growing Use Of Local Anesthetic In Post-Operative Pain

3.3.1.2 Introduction Of New Drugs And Advancement In Technologies

3.3.2 Industry Challenges

3.3.2.1 Dose-Dependent Side Effects And Limited Duration Of Action

3.4 Prospective Growth Scenario

3.4.1 Product Growth Scenario

3.4.2 Application Growth Scenario

3.4.3 Distribution Channel Growth Scenario

3.5 COVID-19 Influence over Industry Growth

3.7 Porter’s Analysis

3.7 PESTEL Analysis

3.8 Value Chain & Supply Chain Analysis

3.9 Regulatory Framework

3.9.1 North America

3.9.2 Europe

3.9.3 APAC

3.9.4 LATAM

3.9.5 MEA

3.10 Technology Overview

3.11 Market Share Analysis, 2020

3.11.1 Company Positioning Overview, 2020

Chapter 4 Local Anesthesia Drugs Market, By Product

4.1 Product Outlook

4.2 Bupivacaine

4.2.1 Market Size, By Region, 2019-2026 (USD Million)

4.3 Ropivacaine

4.3.1 Market Size, By Region, 2019-2026 (USD Million)

4.4 Lidocaine

4.4.1 Market Size, By Region, 2019-2026 (USD Million)

4.5 Chloroprocaine

4.5.1 Market Size, By Region, 2019-2026 (USD Million)

4.6 Prilocaine

4.6.1 Market Size, By Region, 2019-2026 (USD Million)

4.7 Benzocaine

4.7.1 Market Size, By Region, 2019-2026 (USD Million)

Chapter 5 Local Anesthesia Drugs Market, By Application

5.1 Application Outlook

5.2 Injectable

5.2.1 Market Size, By Region, 2019-2026 (USD Million)

5.3 Surface Anesthetic

5.3.1 Market Size, By Region, 2019-2026 (USD Million)

Chapter 6 Local Anesthesia Drugs Market, By Distribution Channel

6.1 Distribution Channel Outlook

6.2 Hospital Pharmacy

6.2.1 Market Size, By Region, 2019-2026 (USD Million)

6.3 Pharmacy Stores

6.3.1 Market Size, By Region, 2019-2026 (USD Million)

6.4 Others

6.4.1 Market Size, By Region, 2019-2026 (USD Million)

Chapter 7 Local Anesthesia Drugs Market, By Region

7.1 Regional outlook

7.2 North America

7.2.1 Market Size, By Country 2019-2026 (USD Million)

7.2.2 Market Size, By Product, 2019-2026 (USD Million)

7.2.3 Market Size, By Application, 2019-2026 (USD Million)

7.2.4 Market Size, By Distribution Channel, 2019-2026 (USD Million)

7.2.5 U.S.

7.2.5.1 Market Size, By Product, 2019-2026 (USD Million)

7.2.5.2 Market Size, By Application, 2019-2026 (USD Million)

7.2.5.3 Market Size, By Distribution Channel, 2019-2026 (USD Million)

7.2.6 Canada

7.2.6.1 Market Size, By Product, 2019-2026 (USD Million)

7.2.6.2 Market Size, By Application, 2019-2026 (USD Million)

7.2.6.3 Market Size, By Distribution Channel, 2019-2026 (USD Million)

7.3 Europe

7.3.1 Market Size, By Country 2019-2026 (USD Million)

7.3.2 Market Size, By Product, 2019-2026 (USD Million)

7.3.3 Market Size, By Application, 2019-2026 (USD Million)

7.3.4 Market Size, By Distribution Channel, 2019-2026 (USD Million)

7.3.5 Germany

7.3.5.1 Market Size, By Product, 2019-2026 (USD Million)

7.3.5.2 Market Size, By Application, 2019-2026 (USD Million)

7.3.5.3 Market Size, By Distribution Channel, 2019-2026 (USD Million)

7.3.6 UK

7.3.6.1 Market Size, By Product, 2019-2026 (USD Million)

7.3.6.2 Market Size, By Application, 2019-2026 (USD Million)

7.3.6.3 Market Size, By Distribution Channel, 2019-2026 (USD Million)

7.3.7 France

7.3.7.1 Market Size, By Product, 2019-2026 (USD Million)

7.3.7.2 Market Size, By Application, 2019-2026 (USD Million)

7.3.7.3 Market Size, By Distribution Channel, 2019-2026 (USD Million)

7.3.8 Italy

7.3.8.1 Market Size, By Product, 2019-2026 (USD Million)

7.3.8.2 Market Size, By Application, 2019-2026 (USD Million)

7.3.8.3 Market Size, By Distribution Channel, 2019-2026 (USD Million)

7.3.9 Spain

7.3.9.1 Market Size, By Product, 2019-2026 (USD Million)

7.3.9.2 Market Size, By Application, 2019-2026 (USD Million)

7.3.9.3 Market Size, By Distribution Channel, 2019-2026 (USD Million)

7.3.10 Russia

7.3.10.1 Market Size, By Product, 2019-2026 (USD Million)

7.3.10.2 Market Size, By Application, 2019-2026(USD Million)

7.3.10.3 Market Size, By Distribution Channel, 2019-2026 (USD Million)

7.4 Asia Pacific

7.4.1 Market Size, By Country 2019-2026 (USD Million)

7.4.2 Market Size, By Product, 2019-2026 (USD Million)

7.4.3 Market Size, By Application, 2019-2026 (USD Million)

7.4.4 Market Size, By Distribution Channel, 2019-2026 (USD Million)

7.4.5 China

7.4.5.1 Market Size, By Product, 2019-2026 (USD Million)

7.4.5.2 Market Size, By Application, 2019-2026 (USD Million)

7.4.5.3 Market Size, By Distribution Channel, 2019-2026 (USD Million)

7.4.6 India

7.4.6.1 Market Size, By Product, 2019-2026 (USD Million)

7.4.6.2 Market Size, By Application, 2019-2026 (USD Million)

7.4.6.3 Market Size, By Distribution Channel, 2019-2026 (USD Million)

7.4.7 Japan

7.4.7.1 Market Size, By Product, 2019-2026 (USD Million)

7.4.7.2 Market Size, By Application, 2019-2026 (USD Million)

7.4.7.3 Market Size, By Distribution Channel, 2019-2026 (USD Million)

7.4.8 Australia

7.4.8.1 Market Size, By Product, 2019-2026 (USD Million)

7.4.8.2 Market size, By Application, 2019-2026 (USD Million)

7.4.8.3 Market Size, By Distribution Channel, 2019-2026 (USD Million)

7.4.9 South Korea

7.4.9.1 Market Size, By Product, 2019-2026 (USD Million)

7.4.9.2 Market Size, By Application, 2019-2026 (USD Million)

7.4.9.3 Market Size, By Distribution Channel, 2019-2026 (USD Million)

7.5 Latin America

7.5.1 Market Size, By Country 2019-2026 (USD Million)

7.5.2 Market Size, By Product, 2019-2026 (USD Million)

7.5.3 Market Size, By Application, 2019-2026 (USD Million)

7.5.4 Market Size, By Distribution Channel, 2019-2026 (USD Million)

7.5.5 Brazil

7.5.5.1 Market Size, By Product, 2019-2026 (USD Million)

7.5.5.2 Market Size, By Application, 2019-2026 (USD Million)

7.5.5.3 Market Size, By Distribution Channel, 2019-2026 (USD Million)

7.5.6 Mexico

7.5.6.1 Market Size, By Product, 2019-2026 (USD Million)

7.5.6.2 Market Size, By Application, 2019-2026 (USD Million)

7.5.6.3 Market Size, By Distribution Channel, 2019-2026 (USD Million)

7.5.7 Argentina

7.5.7.1 Market Size, By Product, 2019-2026 (USD Million)

7.5.7.2 Market Size, By Application, 2019-2026 (USD Million)

7.5.7.3 Market Size, By Distribution Channel, 2019-2026 (USD Million)

7.7 MEA

7.7.1 Market Size, By Country 2019-2026 (USD Million)

7.7.2 Market Size, By Product, 2019-2026 (USD Million)

7.7.3 Market Size, By Application, 2019-2026 (USD Million)

7.7.4 Market Size, By Distribution Channel, 2019-2026 (USD Million)

7.7.5 Saudi Arabia

7.7.5.1 Market Size, By Product, 2019-2026 (USD Million)

7.7.5.2 Market Size, By Application, 2019-2026 (USD Million)

7.7.5.3 Market Size, By Distribution Channel, 2019-2026 (USD Million)

7.7.6 UAE

7.7.6.1 Market Size, By Product, 2019-2026 (USD Million)

7.7.6.2 Market Size, By Application, 2019-2026 (USD Million)

7.7.6.3 Market Size, By Distribution Channel, 2019-2026 (USD Million)

7.7.7 South Africa

7.7.7.1 Market Size, By Product, 2019-2026 (USD Million)

7.7.7.2 Market Size, By Application, 2019-2026 (USD Million)

7.7.7.3 Market Size, By Distribution Channel, 2019-2026 (USD Million)

Chapter 8 Company Landscape

8.1 Competitive Analysis, 2020

8.2 Fresenius Kabi USA, LLC

8.2.1 Company Overview

8.2.2 Financial Analysis

8.2.3 Strategic Positioning

8.2.4 Info Graphic Analysis

8.3 Pfizer Inc.

8.3.1 Company Overview

8.3.2 Financial Analysis

8.3.3 Strategic Positioning

8.3.4 Info Graphic Analysis

8.4 Advanced Pharma, Inc.

8.4.1 Company Overview

8.4.2 Financial Analysis

8.4.3 Strategic Positioning

8.4.4 Info Graphic Analysis

8.5 Akorn, Inc.

8.5.1 Company Overview

8.5.2 Financial Analysis

8.5.3 Strategic Positioning

8.5.4 Info Graphic Analysis

8.6 Teva Pharmaceutical Industries Ltd.

8.6.1 Company Overview

8.6.2 Financial Analysis

8.6.3 Strategic Positioning

8.6.4 Info Graphic Analysis

8.7 Akorn, Inc.

8.7.1 Company Overview

8.7.2 Financial Analysis

8.7.3 Strategic Positioning

8.7.4 Info Graphic Analysis

8.8 Glenmark Pharmaceuticals, Inc.

8.8.1 Company Overview

8.8.2 Financial Analysis

8.8.3 Strategic Positioning

8.8.4 Info Graphic Analysis

8.9 Baxter International, Inc.

8.9.1 Company Overview

8.9.2 Financial Analysis

8.9.3 Strategic Positioning

8.9.4 Info Graphic Analysis

8.10 Astrazeneca PLC

8.10.1 Company Overview

8.10.2 Financial Analysis

8.10.3 Strategic Positioning

8.10.4 Info Graphic Analysis

8.11 Abbott Laboratories

8.11.1 Company Overview

8.11.2 Financial Analysis

8.11.3 Strategic Positioning

8.11.4 Info Graphic Analysis

8.12 F. Hoffmann-La Roche Ltd.

8.12.1 Company Overview

8.12.2 Financial Analysis

8.12.3 Strategic Positioning

8.12.4 Info Graphic Analysis

8.13 Hikma Pharmaceuticals PLC

8.13.1 Company Overview

8.13.2 Financial Analysis

8.13.3 Strategic Positioning

8.13.4 Info Graphic Analysis

8.14 Hospira, Inc.

8.14.1 Company Overview

8.14.2 Financial Analysis

8.14.3 Strategic Positioning

8.14.4 Info Graphic Analysis

8.15 AbbVie Inc.

8.15.1 Company Overview

8.15.2 Financial Analysis

8.15.3 Strategic Positioning

8.15.4 Info Graphic Analysis

8.16 Fresenius Se & Co. KGAA

8.16.1 Company Overview

8.16.2 Financial Analysis

8.16.3 Strategic Positioning

8.16.4 Info Graphic Analysis

8.17 Other Companies

8.17.1 Company Overview

8.17.2 Financial Analysis

8.17.3 Strategic Positioning

8.17.4 Info Graphic Analysis

The Global Local Anesthesia Drugs Market has been studied from the year 2019 till 2026. However, the CAGR provided in the report is from the year 2021 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Local Anesthesia Drugs Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe. Privacy

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

What is the projected market size of the global local anesthesia drugs market?

The global local anesthesia drugs market size is projected to grow from USD 5.60 billion in 2021 to USD 6.75 billion by 2026, at a CAGR of 3.8% during the forecast period.

Who are the major vendors in the local anesthesia drugs market?

Key and innovative vendors in the local anesthesia drugs market include Fresenius Kabi USA, LLC, Pfizer Inc., Advanced Pharma, Inc., Akorn, Inc. Teva Pharmaceutical Industries Ltd., Akorn, Inc., Glenmark Pharmaceuticals, Inc., Baxter International, Inc., AstraZeneca PLC, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Hikma Pharmaceuticals PLC, Hospira, Inc., AbbVie Inc., Fresenius Se & Co. Kgaa, and Novartis AG.

Which region has the highest market share in the local anesthesia drugs market?

North America is estimated to hold the highest market share in the local anesthesia drugs market.

What is the Covid-19 impact on future local anesthesia drugs manufacturers?

Globally, Covid-19 impact on the future local anesthesia drugs market will be quite significant for the manufacturers. North America would be leading because of the increasing number of surgeries being conducted in this area. Subsequently, the Asia Pacific market will be growing the fastest because of the expanding geriatric population requiring surgeries.

What are the major drivers in the local anesthesia drugs market?

The major driving factors for the local anesthesia drugs market include increasing volume of surgeries; growing patient pool; rising geriatric population; increasing technological advancements; soaring requirement and inclination for innovative drugs, upsurge in government initiatives; rising funding on healthcare; rising investments from key players; increasing new pipeline product launches and increasing research & development activities.